Leading Pharma, LLC has recalled 960 bottles of ClomiPRAMINE Hydrochloride (clomipramine) Capsules, 25mg. The recall was issued because testing revealed the medication is "superpotent," containing 110.6% of the active ingredient instead of the intended amount. The affected 100-count bottles are labeled with NDC 69315-167-01 and belong to lot B14221. While no injuries have been reported, consumers should check their medication to see if it is part of this specific batch.
Taking a superpotent drug means the patient receives a higher dose of the medication than their doctor prescribed, which could lead to an accidental overdose or an increase in the frequency and severity of side effects.
You have 2 options:
Rx only; Manufactured by Leading Pharma, LLC in Fairfield, NJ
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.